Answers are grounded in this paper and cite their sources.
Introduction: There is growing emphasis on the development of bioinspired and biohybrid micro/nanorobots for the targeted drug delivery (TDD). Particularly, stimuli-responsive materials and magnetically triggered systems, identified as the most promising materials and design paradigms. Despite the advances made in fabrication and control, there remains a significant gap in clinical translation.Areas covered: This review discusses the opportunities and challenges about micro/nanorobotics for the TDD as evolutionary evidence in bio-nanotechnology, material science, biohybrid robotics, and many more. Important consideration in context with the material’s compatibility/immunogenicity, ethics, and security risk are reported based on the development in artificial intelligence (AI)/machine learning described in literature. The versatility and sophistication of biohybrid components design are being presented, highlighting stimuli-responsive biosystems as smart mechanisms and on-board sensing and control elements.Expert opinion: Focusing on key issues for high controllability at micro- and nano-scale systems in TDD, biohybrid integration strategies, and bioinspired key competences shall be adopted. The promising outlook portraying the commercialization potential and economic viability of micro/nanorobotics will benefit to clinical translation.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: